AbbVie Inc. Quarterly Costs and Expenses in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
AbbVie Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2012 to Q3 2024.
  • AbbVie Inc. Costs and Expenses for the quarter ending September 30, 2024 was $10.6B, a 8.73% decline year-over-year.
  • AbbVie Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $41.7B, a 4.09% increase year-over-year.
  • AbbVie Inc. annual Costs and Expenses for 2023 was $41.6B, a 4.07% increase from 2022.
  • AbbVie Inc. annual Costs and Expenses for 2022 was $39.9B, a 4.35% increase from 2021.
  • AbbVie Inc. annual Costs and Expenses for 2021 was $38.3B, a 11.1% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $41.7B $10.6B -$1.02B -8.73% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $42.7B $10.5B +$1.11B +11.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $41.6B $9.51B +$55M +0.58% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $41.6B $11.1B +$1.49B +15.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $40.1B $11.6B +$1.44B +14.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $38.6B $9.35B -$1.94B -17.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $40.6B $9.46B +$636M +7.21% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $39.9B $9.62B -$193M -1.97% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $40.1B $10.2B +$173M +1.72% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $40B $11.3B +$1.77B +18.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $38.2B $8.82B -$86M -0.97% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $38.3B $9.81B -$293M -2.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $38.6B $10B +$389M +4.03% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $38.2B $9.52B -$155M -1.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $38.3B $8.91B +$3.89B +77.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $34.4B $10.1B +$5.36B +113% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $29.1B $9.65B +$3.79B +64.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $25.3B $9.67B +$4.82B +99.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $20.5B $5.02B +$198M +4.11% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $20.3B $4.75B -$6B -55.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $26.3B $5.86B +$785M +15.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $25.5B $4.86B -$661M -12% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $26.2B $4.82B -$213M -4.23% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $26.4B $10.7B +$4.79B +80.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $21.6B $5.08B +$776M +18% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $20.8B $5.52B +$1.23B +28.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $19.6B $5.03B +$900M +21.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $18.7B $5.96B +$1.48B +32.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $17.2B $4.3B +$230M +5.65% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $17B $4.28B +$217M +5.34% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $16.7B $4.13B +$451M +12.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $16.3B $4.48B +$195M +4.55% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $16.1B $4.07B +$12M +0.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $16.1B $4.07B +$442M +12.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $15.6B $3.68B +$327M +9.75% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $15.3B $4.29B -$1.58B -26.9% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $16.9B $4.06B $0 0% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $16.9B $3.62B +$212M +6.22% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $16.7B $3.35B +$141M +4.39% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $16.5B $5.87B +$2.29B +64.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $14.3B $4.06B +$772M +23.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $13.5B $3.41B +$172M +5.31% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $13.3B $3.21B +$188M +6.22% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $13.1B $3.58B +$191M +5.64% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $12.9B $3.29B +$375M +12.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $12.6B $3.24B +$168M +5.47% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $12.4B $3.02B -$171M -5.35% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $12.6B $3.39B Oct 1, 2012 Dec 31, 2012 10-K 2015-02-20
Q3 2012 $2.91B Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $3.07B Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $3.2B Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.